Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Phase III Trial of Treatment Intensification in Stage II-III Colon Cancer Patients With Positive MRD During Adjuvant Chemotherapy

NCT05534087 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05534087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05534087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Phase III Trial of Treatment Intensification in Stage II-III Colon Cancer Patients With Positive MRD During Adjuvant Chemotherapy
Lead sponsor
Seoul National University Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
December 15, 2022
Completion date
September 30, 2030
Enrollment
236 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer